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Objective: serum elastin peptides (SEP) have been reported to be associated with the expansion of small abdominal aortic
aneurysms (AAA). Consequently, SEP-measurements may predict future rupture, and allow further selection for surgery
in cases referred for surgery due to size.
Material and methods: SEP was measured in 90 men and 10 women with AAA, who were considered for surgery as
part of the Chichester aneurysm screening programme. Sixty-one patients were electively operated and four because of
symptoms. The rest were followed up further. Twelve of these experienced ruptured AAA later.
Results: no correlation between last measured AAA-diameter, annual expansion rate and SEP was noticed. However,
SEP levels were significantly higher in cases rupturing later, persisting after adjustment for age, sex, and last measured
AAA-size. ROC curve analysis concerning SEP as a predictor of rupture later showed an optimal sensitivity and
specificity of 67% and 60%, respectively, similar with last measured AAA-size. By combining AAA-size and SEP, the
optimal sensitivity and specificity reached 83% and 66%, respectively.
Conclusion: one sampling of SEP combined with AAA-size in patients referred for AAA surgery may be a clinical
useful indicator of high rupture risk.
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Introduction and other elastolytic proteases in aneurysmal walls
have been noticed.16–19 The end-products of the el-
Previous reports have described an 0.0–0.5% annual astolytic degradation, serum-elastin-peptides (SEP),
have prospectively been described as a strong pre-rupture rate of abdominal aortic aneurysms (AAA)
below 5 cm in diameter,1–7 while AAA above 5 cm dictor of expansion in small AAA sized 3–5 cm.20
In clinical practice the vascular surgeon often meetsfound at autopsy have an increased risk of rupture
with increasing AAA-size. The risk increases from the patient for the first time, when the patient needs
evaluation for surgery. In order to study this situation,20–50% for AAA with 5–7 cm in diameter to 95% in
AAA above 10 cm in diameter.1,8,9 These autopsy re- the Chichester Screening Programme provides a
unique situation; a relatively large number of previousports have been confirmed by clinical studies sug-
gesting an annual rupture rate of 5–7% in AAA above small screening diagnosed AAA that have been fol-
lowed at intervals depending on AAA size, were5 cm.3,5–7,10–14 At present, the indications for operation
are mainly determined by the size of the aneurysm. referred for surgical evaluation once they reached the
criteria for considering surgery. Blood samples wereAAA under 5 cm can occasionally rupture, while some
large AAA can remain stable for many years.1,8,15 Be- taken at the time of this evaluation. We therefore
measured their SEP levels to see whether they are acause of the variable relationship between AAA size
and risk of rupture, a more specific indicator for predictor of expansion of AAA and whether the SEP
levels were different in asymptomatic cases comparedoperation could be clinically useful.
Elastin is a major component of the human ab- to the cases that came to rupture.
dominal aorta. In AAA, the structure and the amount
of elastin is changed, and increased levels of elastase Material and Methods
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men and women were invited to attend for B-mode not and never became symptomatic as false positives.
The ROC curve analyses were performed using aultrasonographic screening for AAA. An AAA was
non-parametric method in order to test the predictivedefined as an aortic diameter of 30 mm or greater in
value of the tests in predicting expansion to the criteriathe anterior-posterior or transverse plane. Participants
for surgery. For analyses of the ROC curves the nullidentified as having an aortic diameter of 3–5.9 cm
hypothesis was that the test had a performance similarwere offered follow-up examinations at 1 year or 3
to the diagonal line, i.e. the area under the curve wasmonthly intervals, depending on the aortic size; AAA
0.5. If the lowest 95% confidence limit for the area3.0–4.4 cm in diameter were checked annually, AAA
under the curve was above 0.5, a significant predictive4.5–5.9 cm. were rescanned every 3 months. Patients
test was said to be present.with AAA exceeding 6 cm or greater in diameter,
expanding more than 1 cm per annum, or developing
symptoms attributable to the aneurysm were referred
Resultsto the outpatients clinic for consideration for surgery.
In all, 110 patients with AAA were considered for
In Table 1, age, AAA-sizes, observation times, ex-surgery. Of these patients, 90 men and 10 women
pansion rates and SEP levels are shown and classifiedhad blood samples taken once during the outpatients
according to sex. Age at the initial scan and initialevaluation for surgery. Their SEP levels were later
AAA-size were significantly greater in women thanmeasured by our own inhibition type of ELISA per-
in men. The rate of AAA expansion and the meanformed as described earlier20 which is based upon
level of SEP were similar in men and women. Thethe method by Giro and Davidson.21 The intra- and
observation time varied from 0.5 to 11.5 years with ainterassay coefficients of variation were 6% and 10%,
median of 3.14 years, and the median annual expansionrespectively. They were all measured with the same
rate was 3.9 mm, varying from 3 mm to 16 mm an-assay.
nually.Of the 100 patients who had blood samples taken,
In Table 2, subgroup analysis of symptomatic cases65 went on to have an operation. (Four of these due
are compared with asymptomatic cases. SEP levelsto the development of symptoms.) The remaining 35 measured at the evaluation for elective surgery were
cases were either considered unfit for surgery, or were significantly higher in cases that ruptured later, per-
found not to have reached the criteria for surgery, sisting in parametric analysis after adjusting for age,
having been reassessed in the clinic. Follow-up was sex, and last measured AAA-size. The last measured
continued in these 35 remaining patients at three AAA-size were also significantly higher in cases that
month intervals. Of these, 12 died of ruptured AAA, six ruptured later.
underwent emergency surgery, and one was operated SEP-levels tended to be higher in cases that were
acutely because of symptoms. symptomatic when the blood sampling was taken,
In all, the patients were followed up for 1112 years while the last measured AAA-size were significantly
including the observation period before referral for higher in these symptomatic cases. However, there
surgical evaluation. The mean annual expansion rate were only four of such cases. The mean annual ex-
was calculated as the change in the anterior-posterior pansion rate did not differ between cases rupturing
aortic diameter measured using ultrasound during the later and asymptomatic cases, and annual expansion
whole observation period, transformed to annual units rate and last measured AAA diameter did not correlate
(Latest measured max. AP-diameter – max. AP-dia- with concentrations of SEP.
meter at the initial screening diagnosis/observation ROC curve analysis showed that SEP were sig-
time). nificantly predictive for the cases that ruptured later
Data was analysed using EPI6 and SPSS version (area under the curve=0.68, 95% C.I.: 0.52–0.85,
10.0. Wilcoxon’s rank sum test was used as basic test. p<0.05) with an optimal sensitivity and specificity of
In order to adjust for age, sex, last measured AAA- 67% and 60%, respectively. Last measured AAA size
size, logistic regression analysis was used to compare was also significantly predictive for cases that ruptured
later ruptured cases and asymptomatic cases. later (area=0.67, 95% C.I.: 0.51–0.82, p<0.05) with an
Finally, the last measured AAA-size and SEP-levels optimal sensitivity and specificity of 58% and 56%,
were then used in a receiver operating characteristic respectively. By combining the last measured AAA
(ROC) curve. The curve is constructed by finding the size and SEP by multiple linear regression analysis,
sensitivity and specificity for last measured AAA- the optimal sensitivity and specificity reached 83%
size and SEP-levels using those who were or became and 66%, respectively and was significant (area=0.74,
95% C.I.:0.59–0.89, p<0.01) (Fig. 1).symptomatic as true positives, and those who were
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Table 1. Sex differences in patients with abdominal aortic aneurysm referred to preoperative evaluation medians (25% and 75%
quartiles in parentheses).
Initial AAA size Initial age Last AAA size Mean annual S-elastin peptides
(mm) (years) (mm) expansion rate (mg/l)
(mm/year)
Female (n=10) (51.0) 55.5 (62.0) (72.0) 73.5 (79.0) (52.0) 63.0 (77.0) (2.49) 5.37 (5.70) (293) 329 (349)
Male (n=90) (35.0) 42.0 (56.0) (66.0) 70.0 (73.0) (49.0) 54.0 (59.0) (1.36) 2.91 (4.26) (292) 333 (364)
p-value 0.03∗ 0.02∗ 0.01∗ 0.11 0.75
∗ Statistically significant by non-parametric rank sum test.
Table 2. Median age, AAA-size, annual expansion rate and level of S-elastin peptides in patients referred for elective AAA-surgery
including cases developing symptoms or rupture later (25% and 75% quartiles in parentheses).
Initial AAA size Initial age Last AAA size Mean annual S-elastin peptides
(mm) (years) (mm) expansion rate (mg/l)
(mm/year)
Asymptomatic (43) 46 (58) (67) 70 (73) (44) 54 (61) (1.4) 2.8 (4.3) (288) 331 (357)
(n=83)
Symptomatic, (60) 70 (71) (65) 72 (75) (60) 70 (71) (322) 343 (380)
non-ruptured
(n=4)
p-value 0.003∗ 0.946 0.011∗ 0.196
Ruptured AAA (42) 56 (64) (65) 72 (78) (58) 64 (75) (2.9) 4.0 (5.7) (327) 357 (399)
(n=12)
p-value 0.269 0.493 0.046∗ 0.722 0.041∗
∗ Statistically significant by non-parametric rank sum test.
Discussion confounders such as age, sex, and last-measured AAA-
size. Adjustment for smoking habits were considered
SEP-levels at the time of operative evaluation were to cause overadjustment because smoking directly
causes protease secretion with consequently elastinhigher in cases prone to rupture than asymptomatic
cases. The sensitivity and specificity was 67% and degradation and elevated SEP.
The Chichester AAA Study Group has earlier re-60%, respectively, to identify cases prone for rupture,
increasing to 75% and 66%, respectively in combination ported that the variance of their measurements was
1–3 mm,22 which is similar to other reported papers.23–25with last measured AAA-size. The findings may be
expected to be an underestimate since the group of However, the variability of the measurements in-
creases with increasing AAA-diameter, and the casesasymptomatic cases are bound to have cases prone for
rupture if they were left unoperated. in this study are relatively large AAA. Furthermore,
the model for the calculation of expansion rate is linearAll cases were recruited from a screening pro-
gramme. Consequently, questions could be asked because this made a better fit than an exponential
model. However, expansion may not be linear. Rapidwhether the results can be generalised because cases
of screening diagnosed AAA tends to be more healthy expansion the last 6 months before operation occurs
frequently. Whether this is true rapid expansion or athan randomly diagnosed cases. The reason is that
randomly diagnosed cases have consulted the health result of the variation of the measurements is un-
known. However, in all, the expansion rates in thissystem due to health problems. They could in theory
have different SEP-levels due to more frequent pul- study is potential biased. This could explain why, we
were not able to correlate the expansion rate with themonary diseases, and a shorter survival. Both factors
would affect the predictive value. SEP-levels, in spite of a strong correlation reported by
the Viborg Study with the use of the same ELISA-Non-parametric analyses were used because of the
small numbers in the subgroup analyses, and a tend- technique.20 This correlation persisted with increasing
sample size and observation time.26 There may also beency to skew distributions in some of the variables.
However, the distribution of SEP seemed normally additional factors involved; It may be due to different
AAA-sizes at sampling because the aneurysmal elastindistributed. Consequently, parametric tests were used
when asymptomatic cases were compared with cases metabolism depends upon AAA-size. The Viborg
Study performed the serum analysis at the time of thethat ruptured later in order to adjust for potential
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ROC curve data Sensitivity Specificity Area under the curve
(95% C.I.)
S-elastin peptides (ng/ml) 67% 60% 0.68 (0.52–0.85)
Last measured AAA-size (mm) 58% 56% 0.67 (0.51–0.82)
S-elastin peptides and AAA-size 83% 66% 0.74 (0.59–0.89)
Fig. 1. ROC curve analysis for predicting ruptured cases of abdominal aortic aneurysm later with serum elastin-peptides (SEP), last
measured AAA-diameter, and combined model by multiple linear regression analysis with these two predictors as independent variables.
initial screening diagnosis. So their sample was of have demonstrated that increased elastin degradation
also takes place in normal parts of the Aorta in an-smaller AAA with a mean diameter of 3.6 cm. In this
study, we took the samples when the patients were eurysmal cases, and so it is unlikely to be a localised
process of the dilated segment.17referred for surgical evaluation, and the mean AAA
diameter was 5.5 cm. A previous study of small, mod- Last measured AAA-size was, as expected, sig-
nificantly predictive for cases that ruptured in theerate, and large AAA demonstrated that the loss of
elastin starts before a clinically apparent aneurysm is ROC curve analysis. Together with SEP levels the
predictive values becomes more positive especially ifpresent.27 Another explanation could be selection bias
due to case mix with symptomatic cases or a narrowed we take into account the potential underestimation
due to aneurysms tendency to rupture with time evenspectrum of AAA, i.e. they are all clinically relevant
AAA, while the Viborg study consisted of asympto- in the asymptomatic group.
The aim of this study was to see whether AAAmatic small AAA of which only a fraction became
clinically important later. patients with a high risk of rupture could be identified
in order to optimise the indication for operation. OurSEP levels were higher in cases that ruptured later,
and tended to be higher in the symptomatic, non results suggest a potential clinically useful predictive
tool that is based upon the metabolism of elastin inruptured cases. This is in strong contrast to a recent
paper from Petersen et al.,29 who found decreased combination with the AAA size at the time of referral
for surgical assessment, by a vascular surgeon.levels of SEP in cases with contained rupture. Their
explanation was that the AAA were emptied of elastin, The numbers of patients in this study are relatively
small, and the difference in the relative risks of ob-and not that the low levels were due to haemodilution.
However, histological studies of aorta in AAA-cases servation and surgery are also small. The annual risk
Eur J Vasc Endovasc Surg Vol 22, December 2001
J. S. Lindholt et al.550
patients treated nonoperatively. Ann Vasc Surg 1993; 7: 113–116.of rupture in AAA with a diameter of 5–7 cm is 2–5%
14 Scott RA, Tisi PV, Ashton HA, Allen DR. Abdominal aorticwhile the mortality risk of operation is 4–7%. ROC aneurysm rupture rates: a 7 year follow up of the entire ab-
dominal aortic aneurysm population detected by screening. Jcurve analysis based upon a larger number of patients
Vasc Surg 1998; 28: 124–128.could determine the cut point needed to achieve a
15 The UK Small Aneurysm Trial Participants. Mortality results
sensitivity of 95% or more, which might indicate the for randomised controlled trial of early elective surgery or
ultrasonographaic surveillance for small abdominal aorticneed to reduce the frequency of operations, with an
aneurysms. Lancet 1998; 352: 1649–1655.associated reduction in operative mortality and cost.
16 Sans M, Moragas A. Mathematical morphologic analysis of the
This model needs to be validated in a larger pro- aortic medial structure. Biomechanical implications. Analytical
and Quantitative Cytology and Histology 1993; 15: 93–100.spective randomised study, in order to analyse its cost
17 Baxter BT, Davis VA, Minion DJ et al. Abdominal aortic an-effectiveness, before it can be clinical recommended.
eurysms are associated with altered matrix proteins of the non-
aneurysmal aortic segments. J Vasc Surg 1994; 19: 797–802.
18 Brophy CM, Reilly JM, Smith GJW, Tilson MD. The role of
inflammatory infiltrate in non-specific abdominal aortic an-
eurysm disease. Ann Vasc Surg 1991; 5: 229–233.References 19 Cohen JR. Altered aortic protease and antiprotease activity in
patients with ruptured abdominal aortic aneurysm. Surg Gynecol
1 Sterpetti AV, Cavallaro A, Cavallari N et al. Factors in- Obstet 1987; 164: 355–357.
fluencing the rupture of abdominal aortic aneurysms. Surg Gyn- 20 Lindholt JS, Heickendorff L, Fasting H, Henneberg EW.
ecol Obstet 1991; 173: 175–178. Serum-elastin-peptides as predictor for the expansion of small
2 Brown PM. The selective management of small abdominal aortic abdominal aortic aneurysms. Eur J Vasc Endovasc Surg 1997; 14:
aneurysms: the Kingston Study. J Vasc Surg 1992; 15: 21–27. 12–16.
3 Nevitt MP, Ballard DJ, Hallett JW. Prognosis of abdominal 21 Giro GM, Davidson JM. Elastin. Methods in Enzymology 1988;
aortic aneurysms. A population based study. N Engl J Med 1989; 163: 657–673.
321: 1009–1103. 22 Thomas PRS, Shaw JC, Ashton HA, Kay DN, Scott RAP.
4 Greenhaulgh RM, Fowkes FGR, Powell JT, Ruckley CV. When Accuracy of ultrasound in a screening programme for abdominal
should small asymptomatic aneurysms be operated upon? In: aortic aneurysms. J Med Screen 1994; 1: 3–6.
Greenhalgh RM, ed. The Causes and Management of Aneurysms. 23 Lindholt JS, Vammen S, Juul S, Fasting H, Henneberg EW.
London: Saunders, 1990; 457–460. The validity of ultrasonographic scanning as screening method
5 Johansson G. Survival in patients with abdominal aortic an- for abdominal aortic aneurysm. Eur J Vasc Endovasc Surg 1999;
eurysms; comparison between operative and nonoperative man- 17: 472–475.
agement. Eur J Vasc Surg 1990; 4: 497–502. 24 Ellis M, Powell JT, Greenhalgh RM. Limitations of ultra-
6 Scott RAP, Wilson NM, Ashton HA, Kay DN. Is surgery sonography in surveillance of small abdominal aortic aneurysms.
necessary for abdominal aortic aneurysm less than 6 cm in Br J Surg 1981; 78: 614–616.
diameter? Lancet 1993; 342: 1395–1396. 25 Pedersen OM. Ultrasound measurement of the luminal diameter
7 Glima˚ker H, Holmberg L, Elvin A et al. Natural history of of the abdominal aorta and iliac arteries in patients without
patients with abdominal aortic aneurysm. Eur J Vasc Surg 1991; vascular disease. J Vasc Surg 1993; 17: 596–601.
5: 125–130. 26 Lindholt JS, Heickendorff L, Antonsen S, Fasting H, Hen-
neberg EW. The natural history of abdominal aortic aneurysms8 Darling RC. Ruptured arteriosclerotic abdominal aortic an-
with and without chronical obstructive pulmonary disease. Jeurysms. A pathological and clinical Study. Am J Surg 1970; 119:
Vasc Surg 1998; 28: 226–232.397–401.
27 White JV, Haas K, Phillips J, Comerta AJ. Adventitial el-9 Darling RC, Messina CR, Brewster DC, Ottinger LW. Aut-
astolysis is a primary event in aneurysm formation. J Vasc Surgopsy study of unoperated abdominal aortic aneurysms. The case
1993; 17: 371–381.for early resection. Cardiovasc 1976; 56: 161.
28 White JV, Mazzaco SL. Formation and growth of aortic an-10 Flanigan DP. Selective management of high risk patients with
eurysms induced by adventitial elastolysis. In: Tilson DM, Boydan abdominal aortic aneurysm. Surg Gynecol Obstet 1980; 150:
CD, eds. The abdominal aortic aneurysm. New York: The New York171–176.
Academy of Sciences, 1996; 97–120.11 Quriel K. An evaluation of new methods of expressing aortic
29 Petersen E, Geneitis A, A¨ngqvist KA. Serum levels of elastinsize: relationship to rupture. J Vasc Surg 1992; 4: 497–502.
derived peptides in patients with ruptured and asymptomatic12 Szilagyi DE, Elliott JP, Smith RF. Clinical fate of the patients
abdominal aortic aneurysms. Eur J Vasc Endovasc Surg 2001; 22:with asymptomatic abdominal aortic aneurysm unfit for surgical
48–52.treatment. Arch Surg 1972; 104: 600–606.
13 Perko MJ, Schroeder TV, Olsen PS, Jensen LP, Lorentzen JE.
Natural history of abdominal aortic aneurysm: a survey of 63 Accepted 1 September 2001
Eur J Vasc Endovasc Surg Vol 22, December 2001
